Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.

Echevarría-Vargas IM, Reyes-Uribe PI, Guterres AN, Yin X, Kossenkov AV, Liu Q, Zhang G, Krepler C, Cheng C, Wei Z, Somasundaram R, Karakousis G, Xu W, Morrissette JJ, Lu Y, Mills GB, Sullivan RJ, Benchun M, Frederick DT, Boland G, Flaherty KT, Weeraratna AT, Herlyn M, Amaravadi R, Schuchter LM, Burd CE, Aplin AE, Xu X, Villanueva J.

EMBO Mol Med. 2018 Apr 12. pii: e8446. doi: 10.15252/emmm.201708446. [Epub ahead of print]

2.

In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature.

Akbari H, Bakas S, Pisapia JM, Nasrallah MP, Rozycki M, Martinez-Lage M, Morrissette JJD, Dahmane N, O'Rourke DM, Davatzikos C.

Neuro Oncol. 2018 Mar 30. doi: 10.1093/neuonc/noy033. [Epub ahead of print]

PMID:
29617843
3.

A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma.

Windon AL, Loaiza-Bonilla A, Jensen CE, Randall M, Morrissette JJD, Shroff SG.

J Gastrointest Oncol. 2018 Feb;9(1):1-10. doi: 10.21037/jgo.2017.10.14.

4.

ROS1 Rearrangement in a Case of Classic Biphasic Pulmonary Blastoma.

Jenkins TM, Morrissette JJD, Kucharczuk JC, Deshpande CG.

Int J Surg Pathol. 2017 Dec 1:1066896917749928. doi: 10.1177/1066896917749928. [Epub ahead of print]

PMID:
29295663
5.

A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors.

Yam C, Xu X, Davies MA, Gimotty PA, Morrissette JJD, Tetzlaff MT, Wani KM, Liu S, Deng W, Buckley M, Zhao J, Amaravadi RK, Haas NB, Kudchadkar RR, Pavlick AC, Sosman JA, Tawbi H, Walker L, Schuchter LM, Karakousis GC, Gangadhar TC.

Clin Cancer Res. 2018 Jan 1;24(1):22-32. doi: 10.1158/1078-0432.CCR-17-1807. Epub 2017 Oct 19.

PMID:
29051322
6.

Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications.

Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones N, Nicholas P, Ferriola D, Li Y, Huang H, Ye W, Morrissette JJD, Kearns J, Porter DL, Podsakoff GM, Eisenlohr LC, Biegel JA, Chou ST, Monos DS, Bessler M, Olson TS.

Blood Adv. 2017 Oct 10;1(22):1900-1910.

7.

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.

Maxwell KN, Wubbenhorst B, Wenz BM, De Sloover D, Pluta J, Emery L, Barrett A, Kraya AA, Anastopoulos IN, Yu S, Jiang Y, Chen H, Zhang NR, Hackman N, D'Andrea K, Daber R, Morrissette JJD, Mitra N, Feldman M, Domchek SM, Nathanson KL.

Nat Commun. 2017 Aug 22;8(1):319. doi: 10.1038/s41467-017-00388-9.

8.

Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.

Gangadhar TC, Savitch SL, Yee SS, Xu W, Huang AC, Harmon S, Lieberman DB, Soucier D, Fan R, Black TA, Morrissette JJD, Salathia N, Waters J, Zhang S, Toung J, van Hummelen P, Fan JB, Xu X, Amaravadi RK, Schuchter LM, Karakousis GC, Hwang WT, Carpenter EL.

Pigment Cell Melanoma Res. 2018 Jan;31(1):73-81. doi: 10.1111/pcmr.12623. Epub 2017 Oct 23.

PMID:
28786531
9.

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

O'Rourke DM, Nasrallah MP, Desai A, Melenhorst JJ, Mansfield K, Morrissette JJD, Martinez-Lage M, Brem S, Maloney E, Shen A, Isaacs R, Mohan S, Plesa G, Lacey SF, Navenot JM, Zheng Z, Levine BL, Okada H, June CH, Brogdon JL, Maus MV.

Sci Transl Med. 2017 Jul 19;9(399). pii: eaaa0984. doi: 10.1126/scitranslmed.aaa0984.

10.

Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.

Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, Carpenter E, Chodosh LA, DeMichele A.

Breast Cancer Res Treat. 2017 Aug;164(3):639-640. doi: 10.1007/s10549-017-4339-9. No abstract available.

PMID:
28653249
11.

Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.

Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, Carpenter E, Chodosh LA, DeMichele A.

Breast Cancer Res Treat. 2017 Aug;164(3):627-638. doi: 10.1007/s10549-017-4257-x. Epub 2017 May 12. Erratum in: Breast Cancer Res Treat. 2017 Jun 26;:.

PMID:
28500398
12.

Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.

Rogers HJ, Hsi ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JJ, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP.

Am J Clin Pathol. 2017 Apr 1;147(4):411-419. doi: 10.1093/ajcp/aqx020.

PMID:
28375434
13.

Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia.

Tasian SK, Kenderian SS, Shen F, Ruella M, Shestova O, Kozlowski M, Li Y, Schrank-Hacker A, Morrissette JJD, Carroll M, June CH, Grupp SA, Gill S.

Blood. 2017 Apr 27;129(17):2395-2407. doi: 10.1182/blood-2016-08-736041. Epub 2017 Feb 28.

PMID:
28246194
14.

Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.

Hatem J, Schrank-Hacker AM, Watt CD, Morrissette JJ, Rubin AI, Kim EJ, Nasta SD, Wasik MA, Bogusz AM.

Diagn Pathol. 2016 Dec 19;11(1):137.

15.

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors.

Fox AJ, Hiemenz MC, Lieberman DB, Sukhadia S, Li B, Grubb J, Candrea P, Ganapathy K, Zhao J, Roth D, Alley E, Loren A, Morrissette JJ.

J Vis Exp. 2016 Sep 20;(115). doi: 10.3791/52758. Review.

16.

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.

Ruella M, Barrett DM, Kenderian SS, Shestova O, Hofmann TJ, Perazzelli J, Klichinsky M, Aikawa V, Nazimuddin F, Kozlowski M, Scholler J, Lacey SF, Melenhorst JJ, Morrissette JJ, Christian DA, Hunter CA, Kalos M, Porter DL, June CH, Grupp SA, Gill S.

J Clin Invest. 2016 Oct 3;126(10):3814-3826. doi: 10.1172/JCI87366. Epub 2016 Aug 29.

17.

BRAF kinase domain mutations in de novo acute myeloid leukemia with monocytic differentiation.

Xu Y, Wertheim G, Morrissette JJ, Bagg A.

Leuk Lymphoma. 2017 Mar;58(3):743-745. doi: 10.1080/10428194.2016.1213830. Epub 2016 Aug 22. No abstract available.

PMID:
27545333
18.

Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.

Luskin MR, Carroll M, Lieberman D, Morrissette JJD, Zhao J, Crisalli L, Roth DB, Luger SM, Porter DL, Reshef R.

Biol Blood Marrow Transplant. 2016 Nov;22(11):1961-1967. doi: 10.1016/j.bbmt.2016.07.018. Epub 2016 Jul 28.

19.

A novel approach for next-generation sequencing of circulating tumor cells.

Yee SS, Lieberman DB, Blanchard T, Rader J, Zhao J, Troxel AB, DeSloover D, Fox AJ, Daber RD, Kakrecha B, Sukhadia S, Belka GK, DeMichele AM, Chodosh LA, Morrissette JJ, Carpenter EL.

Mol Genet Genomic Med. 2016 Feb 28;4(4):395-406. doi: 10.1002/mgg3.210. eCollection 2016 Jul.

20.

Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience.

Wei S, LiVolsi VA, Montone KT, Morrissette JJ, Baloch ZW.

Endocr Pathol. 2016 Dec;27(4):359-362.

PMID:
27379493
21.

A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia.

Sloan CE, Luskin MR, Boccuti AM, Sehgal AR, Zhao J, Daber RD, Morrissette JJ, Luger SM, Bagg A, Gimotty PA, Carroll M.

PLoS One. 2016 Apr 6;11(4):e0153016. doi: 10.1371/journal.pone.0153016. eCollection 2016.

22.

Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing.

Hiemenz MC, Kadauke S, Lieberman DB, Roth DB, Zhao J, Watt CD, Daber RD, Morrissette JJ.

PLoS One. 2016 Apr 4;11(4):e0152851. doi: 10.1371/journal.pone.0152851. eCollection 2016.

23.

Familial Monosomy 7 Syndrome.

Morrissette JJD, Wertheim G, Olson T.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2010 Jul 8 [updated 2016 Jan 21].

24.

Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.

Wei S, Lieberman D, Morrissette JJ, Baloch ZW, Roth DB, McGrath C.

Cancer Cytopathol. 2016 May;124(5):324-9. doi: 10.1002/cncy.21666. Epub 2015 Dec 18.

25.

STK11 Mutation Identified in Thyroid Carcinoma.

Wei S, LiVolsi VA, Brose MS, Montone KT, Morrissette JJ, Baloch ZW.

Endocr Pathol. 2016 Mar;27(1):65-9. doi: 10.1007/s12022-015-9411-6.

PMID:
26662608
26.

Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm.

Aikawa V, Porter D, Luskin MR, Bagg A, Morrissette JJ.

Cancer Genet. 2015 Dec;208(12):625-9. doi: 10.1016/j.cancergen.2015.10.003. Epub 2015 Nov 3.

PMID:
26628205
27.

PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.

Wei S, LiVolsi VA, Montone KT, Morrissette JJ, Baloch ZW.

Endocr Pathol. 2015 Dec;26(4):365-9. doi: 10.1007/s12022-015-9403-6.

PMID:
26530486
28.

Multiple Gastrointestinal Polyps in Patients Treated with BRAF Inhibitors.

Amaravadi RK, Hamilton KE, Ma X, Piao S, Portillo AD, Nathanson KL, Carlino MS, Long GV, Puzanov I, Xu X, Morrissette JJ, Tsai KY, Flaherty KT, Sosman JA, Goodman GR, McArthur GA, Rustgi AK, Metz DC, Schuchter LM, Chapman PB, Sepulveda AR.

Clin Cancer Res. 2015 Dec 1;21(23):5215-21. doi: 10.1158/1078-0432.CCR-15-0469. Epub 2015 Jul 22.

29.

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features.

Luskin MR, Huen AO, Brooks SA, Stewart C, Watt CD, Morrissette JJ, Lieberman DB, Bagg A, Rosenbach M, Perl AE.

Haematologica. 2015 Oct;100(10):e412-4. doi: 10.3324/haematol.2015.129346. Epub 2015 Jun 25. No abstract available.

30.

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia.

Kenderian SS, Ruella M, Shestova O, Klichinsky M, Aikawa V, Morrissette JJ, Scholler J, Song D, Porter DL, Carroll M, June CH, Gill S.

Leukemia. 2015 Aug;29(8):1637-47. doi: 10.1038/leu.2015.52. Epub 2015 Feb 27.

31.

Development and implementation of a custom integrated database with dashboards to assist with hematopathology specimen triage and traffic.

Azzato EM, Morrissette JJ, Halbiger RD, Bagg A, Daber RD.

J Pathol Inform. 2014 Aug 28;5(1):29. doi: 10.4103/2153-3539.139709. eCollection 2014.

32.

What you are missing could matter: a rare, complex BRAF mutation affecting codons 599, 600, and 601 uncovered by next generation sequencing.

Wilson MA, Morrissette JJ, McGettigan S, Roth D, Elder D, Schuchter LM, Daber RD.

Cancer Genet. 2014 Jun;207(6):272-5. doi: 10.1016/j.cancergen.2014.06.022. Epub 2014 Jun 18.

PMID:
25178945
33.

'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients.

Landsburg DJ, Nasta SD, Svoboda J, Morrissette JJ, Schuster SJ.

Br J Haematol. 2014 Aug;166(3):369-74. doi: 10.1111/bjh.12901. Epub 2014 Apr 25.

PMID:
24761809
34.

Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets.

Daber R, Sukhadia S, Morrissette JJ.

Cancer Genet. 2013 Dec;206(12):441-8. doi: 10.1016/j.cancergen.2013.11.005. Epub 2013 Nov 28. Review.

PMID:
24528889
35.

Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.

Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, Arber D, Moore E, Morrissette JJ, Bagg A, Liu YC, Mathew S, Orazi A, Lin P, Wang SA, Bueso-Ramos CE, Foucar K, Hasserjian RP, Tiu RV, Karafa M, Hsi ED.

Haematologica. 2014 May;99(5):821-9. doi: 10.3324/haematol.2013.096420. Epub 2014 Jan 24.

36.

Reply: To PMID 23529082.

Mennuti MT, Dugoff L, Morrissette JJ, Cherry AM.

Am J Obstet Gynecol. 2014 Jul;211(1):81. doi: 10.1016/j.ajog.2014.01.015. Epub 2014 Jan 10. No abstract available.

PMID:
24418226
37.

BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.

Raess PW, Mintzer D, Husson M, Nakashima MO, Morrissette JJ, Daber R, Bagg A.

Blood. 2013 Oct 24;122(17):3084-5. doi: 10.1182/blood-2013-07-513523. No abstract available.

38.

Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?

Mennuti MT, Cherry AM, Morrissette JJ, Dugoff L.

Am J Obstet Gynecol. 2013 Nov;209(5):415-9. doi: 10.1016/j.ajog.2013.03.027. Epub 2013 Mar 22.

PMID:
23529082
39.

Acute myeloid leukemia: conventional cytogenetics, FISH, and moleculocentric methodologies.

Morrissette JJ, Bagg A.

Clin Lab Med. 2011 Dec;31(4):659-86, x. doi: 10.1016/j.cll.2011.08.006. Review.

PMID:
22118743
41.

Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome.

Chandra HS, Heisterkamp NC, Hungerford A, Morrissette JJ, Nowell PC, Rowley JD, Testa JR.

Cancer Genet. 2011 Apr;204(4):171-9. doi: 10.1016/j.cancergen.2011.03.002.

42.

Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.

Bauer RC, Laney AO, Smith R, Gerfen J, Morrissette JJ, Woyciechowski S, Garbarini J, Loomes KM, Krantz ID, Urban Z, Gelb BD, Goldmuntz E, Spinner NB.

Hum Mutat. 2010 May;31(5):594-601. doi: 10.1002/humu.21231.

43.

Hyperdiploidy with trisomy 9 and deletion of the CDKN2A locus in T-cell acute lymphoblastic leukemia.

Healey K, Gray SL, Halligan GE, McKenzie AS, de Chadarévian JP, Morrissette JJ.

Cancer Genet Cytogenet. 2009 Apr 15;190(2):121-4. doi: 10.1016/j.cancergencyto.2008.12.012.

PMID:
19380031
44.

Improvement of pancytopenia and thrombocytopenia with decreasing mosaicism for isochromosome Xp.

Gray SL, de Chadarévian JP, Anderson CE, Shafer FE, Punnett HH, Morrissette JJ.

Pediatr Blood Cancer. 2009 May;52(5):650-2. doi: 10.1002/pbc.21890.

PMID:
19145639
45.

Study of an ovarian sclerosing stromal tumor presenting as vaginal bleeding in a 7-month-old.

Hall OR, Pascasio JM, Morrissette JJ, Newton C, Schwartz MZ, de Chadarévian JP.

Pediatr Dev Pathol. 2008 Jul-Aug;11(4):300-4. Epub 2007 Aug 22.

PMID:
17990931
46.

Down syndrome with low hypodiploidy in precursor B-cell acute lymphoblastic leukemia.

Morrissette JJ, Halligan GE, Punnett HH, McKenzie AS, Guerrero F, de Chadarévian JP.

Cancer Genet Cytogenet. 2006 Aug;169(1):58-61.

PMID:
16875938
47.

Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate.

Warthen DM, Moore EC, Kamath BM, Morrissette JJ, Sanchez-Lara PA, Piccoli DA, Krantz ID, Spinner NB.

Hum Mutat. 2006 May;27(5):436-43. Erratum in: Hum Mutat. 2013 Feb;34(2):408. Sanchez, P [corrected to Sanchez-Lara, P A].

PMID:
16575836
48.

A patient with mosaic partial trisomy 18 resulting from dicentric chromosome breakage.

Morrissette JJ, Medne L, Bentley T, Owens NL, Geiger E, Pipan M, Zackai EH, Shaikh T, Spinner NB.

Am J Med Genet A. 2005 Aug 30;137(2):208-12.

PMID:
16082706
49.

Patient with trisomy 9p and a hypoplastic left heart with a tricentric chromosome 9.

Morrissette JJ, Laufer-Cahana A, Medne L, Russell KL, Venditti CP, Kline R, Zackai EH, Spinner NB.

Am J Med Genet A. 2003 Dec 15;123A(3):279-84.

PMID:
14608650
50.

Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage.

Lu F, Morrissette JJ, Spinner NB.

Am J Hum Genet. 2003 Apr;72(4):1065-70. Epub 2003 Mar 14.

Supplemental Content

Loading ...
Support Center